As we move into the future of clinical trials, artificial intelligence (AI) is playing a more integral role than ever. AI enables more accurate analyses of data points, faster results that can provide improved accuracy compared to older methods, and technology-driven improvements in identifying patterns within large datasets. In this 7-part series, we will explore how AI is revolutionizing the world of clinical research, from virtual trial design to patient recruitment and safety monitoring during trials through to post-marketing assessments for drug development teams. Alongside this information-rich series of blog posts – readers will gain all the necessary knowledge about AI’s impact on clinical trials that they need to be informed decision makers.
Part #1: Revolutionizing Clinical Trials: How AI is Streamlining the Drug Development Process
Part #2: How AI Can Improve Data Collection And Analysis In Clinical Trials
Part #3: The Ethical and Regulatory Considerations Surrounding the Use of AI in Clinical Trials
How AI Can Be Used to Improve Patient Recruitment and Retention in Clinical Trials
One of the biggest challenges in clinical research today is patient recruitment and retention. It’s estimated that 50% of trials fail because they don’t have enough patients, and that roughly one-third of all participants drop out before the trial is completed. This has serious implications for the cost, time, and accuracy of clinical trials; however, there may be a solution in sight—artificial intelligence (AI). In this blog post, we will explore how AI can be used to improve patient recruitment and retention in clinical trials.
AI-Powered Recruitment Platforms
One way AI can be used to improve patient recruitment is by using AI-powered recruitment platforms. These platforms use natural language processing (NLP) algorithms to quickly scan through large amounts of data for relevant information about potential participants. For example, NLP algorithms can be used to mine electronic health records (EHRs) for information about a patient’s age, gender, diagnosis, medications taken, etc.—allowing researchers to quickly identify those who meet their criteria for participation. This helps reduce the amount of time spent recruiting participants as well as increase the accuracy of participant selection since researchers are able to quickly narrow down their search results.
AI-Powered Retention Strategies
AI can also be used to improve patient retention in clinical trials by leveraging predictive analytics tools. These tools use machine learning algorithms to analyze data from EHRs and other sources in order to accurately predict which patients are more likely to drop out or miss appointments during a trial. This allows researchers to take pre-emptive action by targeting at-risk patients with personalized interventions designed specifically for them—increasing the likelihood that they will remain enrolled in the study.
AI-Enabled Clinical Trial Management Solutions
Finally, AI can also be used to streamline other aspects of clinical trial management such as data collection and monitoring processes. For example, some AI-enabled solutions use facial recognition technology or voice recognition software to collect data from participants without requiring them to enter it manually into an app or website. This not only saves time but also reduces errors due to incorrect data entry. Additionally, some solutions leverage real-time monitoring capabilities that enable researchers to track participant adherence more closely and take corrective action when needed—thereby helping reduce attrition rates caused by poor compliance with protocols or procedures.
Conclusion
Artificial intelligence has tremendous potential when it comes to improving patient recruitment and retention rates in clinical trials. By leveraging AI-powered platforms for participant selection and retention strategies backed by predictive analytics tools, researchers can save time while ensuring accurate results—ultimately leading to better outcomes for both patients and sponsors alike! Ultimately, harnessing the power of AI could revolutionize the way we conduct clinical trials moving forward—making them faster and more efficient than ever before!
Communications automation is the future of clinical trials, happening now. Use Mosio mobile messaging software to improve engagement, adherence, and data collection in your clinical trials, available on every mobile device. Get a quote for any current or upcoming studies you have or contact us for a demo.
Note: The titles, content and artwork for the articles in this series were all created by AI.
